| prevalence of htlv types i and ii among drug users in king county, washington. | we investigated the prevalence of human t-cell lymphotropic virus (htlv) types i and ii among drug users entering treatment in king county, washington, between 1988 and 1990. of 762 injection-drug users, 81 (10.6%) were htlv-positive; of 89 noninjection-drug users, 2 (2%) were htlv-positive. most (95.8%) of those typed) were htlv-ii-positive. the relationship between htlv and demographic and behavioral characteristics was further evaluated among injection-drug users. the prevalence rates for htl ... | 1994 | 8053176 |
| htlv-i in alaska natives. | | 1993 | 8450413 |
| prevalence of htlv-i in arctic regions. | sera of native inhabitants of arctic regions were assayed for antibodies to htlv-i by the elisa technique followed by competition experiments to confirm antibody specificity. residents of 7 widely separated alaskan villages exhibited prevalence rates of 0 to 12% for htlv-i antibodies. less than 1% of greenland eskimos were htlv-i antibody-positive. residents of 3 northern swedish regions ranged in htlv-i antibody prevalence from 0 to 5%. sera of healthy native inhabitants of alaska and northern ... | 1985 | 2999005 |
| atypical human t-cell lymphotropic virus type-i-associated t-cell lymphoma in a low-prevalence alaska native population. implications for disease surveillance. | an atypical case of adult t-cell leukemia/lymphoma (atl) associated with human t-cell lymphotropic virus type i (htlv-i) occurred in a 46-year-old inupiat eskimo man with no behavioral risk factors for htlv-i infection. the case was characterized by lack of atypical circulating lymphocytes, hypercalcemia, and opportunistic infections; and by complete remission of the initial renal parenchymal lymphoma. the lymphoma cells had a helper t-cell (cd4) immunophenotype. serum antibodies to htlv i/ii, d ... | 1993 | 8099530 |